Precision Medicine in Pediatric Autoimmunity: Leniolisib Treatment of Childhood‐Onset Lupus Nephritis Due to Activated Phosphoinositide 3‐Kinase δ Syndrome

Documenti analoghi

• Renal Response Outcomes of the EuroLupus and National Institutes of Health Cyclophosphamide Dosing Regimens in Childhood‐Onset Proliferative Lupus Nephritis
  di: Christine S. Wang, et al.
  Pubblicazione: (2024)
• Genetics of Childhood‐Onset Systemic Lupus Erythematosus
  di: Raffaella Carlomagno, et al.
  Pubblicazione: (2025)
• Implications of Inflammatory Processes on a Developing Central Nervous System in Childhood‐Onset Systemic Lupus Erythematosus
  di: Hanne van der Heijden, et al.
  Pubblicazione: (2024)
• Therapeutic Targeting Protein Kinase CK2 Ameliorates Lupus Nephritis by Modulating Neutrophil Infiltration and Neutrophil Extracellular Trap Formation
  di: Minghua Zhan, et al.
  Pubblicazione: (2026)
• Podocyte Interleukin‐23 Receptor Signaling in the Pathogenesis of Lupus Nephritis
  di: Rong Fu, et al.
  Pubblicazione: (2025)